Cardlytics

Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The Cardlytics Direct segment represents its proprietary native bank advertising channel. The Other Platform Solutions segment includes solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded by Scott D. Grimes, Lynne M. Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cardlytics reports robust Q4 performance and eyes positive cash flow

Cardlytics delivered a strong performance in Q4 2022, marked by robust financial results and operational improvements.
The company's strategic focus on cost management, product enhancements, and consumer engagement bodes well for future growth.
While facing challenges in a competitive landscape, Cardlytics is poised to capitalize on opportunities through innovation and strategic initiatives.
Guidance for Q1 2023 and the target for positive free cash flow in Q3 2023 reflect a positive outlook for the company's financial health.

Cardlytics (CDLX) surpasses Q1 expectations amidst cautious advertiser sentiment

Cardlytics (CDLX) reported strong Q1 2023 earnings, exceeding expectations with growth in unique consumers activating offers and improved cost discipline.
The company faces challenges from cautious advertisers and client concentration risks, requiring strategic management and diversification efforts.
Opportunities for growth include expanding the partner network, driving user engagement, and innovating in product offerings to maintain competitiveness.

Cardlytics reports mixed Q2 results, eyes partnerships for growth

Cardlytics navigated mixed financial results in Q2 2023, focusing on cost optimizations and strategic initiatives. The company aims for positive annual adjusted EBITDA and operating cash flow in 2024 amidst market variability and economic uncertainty.

Cardlytics reports positive Q3 results, eyes global expansion and new products

Cardlytics delivered positive Q3 results, showcasing growth in revenue, partnerships, and strategic initiatives. Challenges include revenue factors and product adoption, while opportunities exist in new product offerings and global expansion. The company remains optimistic about future prospects and business success.

Cardlytics reports record Q4 earnings, eyes growth through redemptions

Cardlytics achieved a milestone with its first positive annual adjusted EBITDA since 2019 and recorded its largest adjusted EBITDA in Q4. The company is strategically positioned for growth with new partnerships, product launches, and a focus on driving redemptions. Challenges lie in maintaining financial performance and capital structure.

Cardlytics (CDLX) posts robust Q1 results, eyes growth opportunities

Cardlytics (CDLX) reported strong Q1 2024 results with notable billings and revenue growth, positive adjusted EBITDA, and progress in strategic initiatives. While facing challenges in Q2 projections and analyst inquiries, the company remains focused on capitalizing on growth opportunities and market trends.

Cardlytics reports mixed Q2 results, focuses on growth opportunities

Cardlytics shows resilience with positive adjusted EBITDA in 2023 and improved financial stability
Despite missing Q2 guidance, the company is addressing delivery issues and focusing on growth areas
Strong relationships with financial institutions and plans for business evolution under new leadership
Q3 outlook includes challenges but also opportunities for expansion and performance acceleration

Cardlytics faces Q3 revenue decline, eyes growth through strategic investments

Cardlytics navigated Q3 challenges with a focus on enhancing key aspects of its business. The company's strategic priorities include supply, demand, network performance, and investments in growth initiatives like Bridg and Rippl.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Although Cardlytics Inc (NASDAQ: CDLX) reported strong results for the second quarter, its monetization prospects are not as bright as was earlier anticipated, according to KeyBanc Capital Markets.

KeyBanc Downgrades Cardlytics On Valuation, Reduced Estimates

The purchase-intelligence platform company beat second-quarter estimates and increased its full-year guidance.

Why Cardlytics Stock Popped Today.

Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 47.83% and 11.23%, respectively, for the quarter ended June 2019.

Cardlytics, Inc. (CDLX) Reports Q2 Loss, Tops Revenue Estimates

Cardlytics, Inc. (CDLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

Analysts Estimate Cardlytics, Inc. (CDLX) to Report a Decline in Earnings: What to Look Out for

Does Cardlytics, Inc. (CDLX) have what it takes to be a top stock pick for momentum investors?

Here's Why Momentum Investors Will Love Cardlytics, Inc. (CDLX)

Cardlytics, Inc. (CDLX) is at a 52-week high, but can investors hope for more gains in the future?

Cardlytics, Inc. (CDLX) Hits 52-Week High, Can the Run Continue?

Cardlytics, Inc. (CDLX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects.

All You Need to Know About Cardlytics, Inc. (CDLX) Rating Upgrade to Strong Buy

Cardlytics, Inc. (CDLX) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Moving Average Crossover Alert: Cardlytics

Cardlytics (CDLX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

Cardlytics (CDLX) Catches Eye: Stock Jumps 7.4%

As of late, it has definitely been a great time to be an investor in Cardlytics, Inc. (CDLX).

Cardlytics, Inc. (CDLX) Shares March Higher, Can It Continue?

Cardlytics, Inc. (CDLX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cardlytics, Inc. (CDLX) Upgraded to Buy: Here's Why

The operator of bank loyalty programs reported strong earnings.

Why Cardlytics Shares Jumped Today

Cardlytics, Inc. (CDLX) delivered earnings and revenue surprises of 37.84% and -0.03%, respectively, for the quarter ended March 2019.

News for Cardlytics Stock (CDLX)